Innate Pharma S.A. ADR (IPHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select FieldsSymbol | IPHA | KYTX | FENC | ||
Company | Innate Pharma S.A. ADR | Kyverna Therapeutics Inc | Fennec Pharmaceuticals Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 2.07 | 3.86 | 6.13 | ||
High | 2.12 | 4.08 | 6.47 | ||
Low | 2.03 | 3.85 | 6.12 | ||
Last | 2.11 | 3.98 | 6.37 | ||
Change | +0.05 | +0.02 | +0.18 | ||
% Change | +2.43% | +0.51% | +2.91% | ||
Volume | 41,700 | 157,200 | 94,900 | ||
20-Day Average Volume | 1,474,585 | 417,075 | 135,700 | ||
Previous Close | 2.06 | 3.96 | 6.19 | ||
Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 1.88 | 4.61 | 6.06 | ||
20-Day Raw Stochastic | 33.32% | 9.93% | 82.88% | ||
20-Day Relative Strength | 53.64% | 41.47% | 61.95% | ||
Weighted Alpha | -52.60 | -88.06 | -37.24 | ||
Today's Opinion | 16% Sell | 100% Sell | 8% Buy | ||
Previous Opinion | 24% Sell | 100% Sell | 8% Buy | ||
Last Month's Opinion | 100% Sell | 88% Sell | 40% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | -2.31% since 12/18/24 | +5.01% since 12/18/24 | +12.54% since 12/18/24 | ||
Low | 2.01 on 12/23/24 | 3.63 on 12/19/24 | 5.51 on 12/19/24 | ||
High | 2.18 on 12/19/24 | 4.09 on 12/20/24 | 6.47 on 12/26/24 | ||
1-Month | |||||
%Chg | +40.67% since 11/26/24 | -21.34% since 11/26/24 | +5.46% since 11/26/24 | ||
Low | 1.41 on 12/04/24 | 3.63 on 12/19/24 | 5.51 on 12/19/24 | ||
High | 3.51 on 12/13/24 | 7.20 on 12/02/24 | 6.55 on 11/27/24 | ||
3-Month | |||||
%Chg | -1.86% since 09/26/24 | -24.19% since 09/26/24 | +23.93% since 09/26/24 | ||
Low | 1.29 on 11/18/24 | 3.63 on 12/19/24 | 3.96 on 11/18/24 | ||
High | 3.51 on 12/13/24 | 7.20 on 12/02/24 | 6.55 on 11/27/24 | ||
6-Month | |||||
%Chg | +4.46% since 06/26/24 | -45.25% since 06/26/24 | +5.81% since 06/26/24 | ||
Low | 1.29 on 11/18/24 | 3.63 on 12/19/24 | 3.96 on 11/18/24 | ||
High | 3.51 on 12/13/24 | 11.40 on 07/16/24 | 6.91 on 07/17/24 | ||
Key Statistics | |||||
Market Capitalization, $K | 170,572 | 170,961 | 170,039 | ||
Shares Outstanding, K | 82,802 | 43,172 | 27,470 | ||
Annual Sales | 66,710,000 | 0 | 21,250,000 | ||
Annual Net Income | -8,190,000 | -60,370,000 | -16,050,000 | ||
Last Quarter Sales | N/A | 0 | 6,970,000 | ||
Last Quarter Net Income | N/A | -34,490,000 | -5,740,000 | ||
60-Month Beta | 0.34 | N/A | 0.35 | ||
Per-Share Information | |||||
Most Recent Earnings | N/A | -0.80 on 11/13/24 | -0.21 on 11/07/24 | ||
Latest Earnings Date | 11/13/24 | 11/11/24 | 11/07/24 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |